Syngene

BSE: 539268 | NSE: SYNGENE
Syngene (CIN: L85110KA1993PLC014937) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Aug 2015. It currents trades on NSE with symbol SYNGENE and on BSE with scrip code 539268.
The registered office of the company is Biocon Park SEZ, Jigani Link Road, Bommasandra IV Phase,Bengaluru,Karnataka,560099.

The management team of Syngene is led by Mayank Verma who is the Company Secretary & Compliance Officer. Other members of the management team consist of Kiran Mazumdar Shaw (Designation:Director), Ms. Vinita Bali (Designation:Director (Independent)), John Mccallum Marshall Shaw (Designation:Director), Catherine Patricia Roseberg (Designation:Director), Jonathan Hunt (Designation:Whole Time Director), John Russell Forthernghan Walls (Designation:Director), Paul Frederick Blacburn (Designation:Director), Bala S Manian (Designation:Director), Suresh N Talwar (Designation:Independent Director), Dr. Vijay Kuchroo (Designation:Non-Executive, Independent Director), .

The price and other financial information of Syngene is as below -

BSE 601.70 7.70 (1.30%)

BSE

601.70 7.70 (1.30%)
Volume: 2,347.00
M. Cap: 12,034.00
P/E: 38.18
Prev. Close: 594.00
Day
52 Wk

NSE

600.65 7.00 (1.18%)
Volume: 19,280.00
M. Cap: 12,034.00
P/E: 38.18
Prev. Close: 593.65
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 14,21,11,675 71.06
Foreign Institutions 3,39,03,268 16.95
General Public 97,20,839 4.86
NBFC and Mutual Funds 78,05,617 3.90
Others 28,30,677 1.42
GDR 21,66,986 1.08
Financial Institutions 14,57,438 0.73
ForeignPromoter 3,500 0.00
Total 20,00,00,000 100

Financial Data

Consolidated
Figures in crore 2018
Net Sales 1,423.10
Operating Profit 526.60
Other Income 135.70
Interest 22.70
Depreciation 131.40
Profit Before Tax 372.50
Tax 67.10
Profit After Tax 305.40
Share Capital 200.00
Reserves 1,520.40
Net Worth 1,720.40
Loans 886.90
Gross Block 1,660.70
Investments 157.70
Cash 967.40
Debtors 266.80
Net Working Capital 1,263.80
Operating Profit Margin (%) 37.00
Net Profit Margin (%) 21.46
Earning Per Share (Rs) 15.06
Dividend (%) 10.00
Dividend Payout 20.00
Standalone
Figures in crore 2018 2017 2016
Net Sales 1,423.10 1,200.90 1,107.00
Operating Profit 526.20 478.30 386.70
Other Income 135.70 93.60 6.30
Interest 22.70 17.50 8.40
Depreciation 131.40 114.30 97.30
Profit Before Tax 372.10 346.50 281.00
Tax 67.00 59.20 40.20
Profit After Tax 305.10 287.30 240.80
Share Capital 200.00 200.00 200.00
Reserves 1,520.10 1,213.10 824.70
Net Worth 1,720.10 1,413.10 1,024.70
Loans 886.90 878.00 962.60
Gross Block 1,660.70 1,331.90 1,111.40
Investments 158.00 540.40 276.60
Cash 966.50 527.30 719.90
Debtors 266.80 198.70 185.20
Net Working Capital 1,263.20 765.40 893.70
Operating Profit Margin (%) 36.98 39.83 34.93
Net Profit Margin (%) 21.44 23.92 21.75
Earning Per Share (Rs) 15.05 14.37 11.84
Dividend (%) 10.00 10.00 10.00
Dividend Payout 20.00 0.00 20.00
Dividend Declared (₹)
The company has declared dividend 3 times between 17 Mar 2016 and 17 Jul 2018, totaling Rs. 3.00 so far. The most dividend was declared on 17 Jul 2018 for Rs. 1.

Financial Data Graph

The peers of Syngene are AUROPHARMA, IOLCP and AJANTPHARM.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*